Drug Topics
MARCH 4, 2025
If CMS doesnt reconsider its mandate, which forces independent pharmacies to go deep into a hole and lose money, many of them will close.
STAT
MARCH 4, 2025
The Food and Drug Administration scolded a company for a promotional display that falsely claimed its brand-name medicine was more effective than generic versions, which is apparently the first time the agency office responsible for monitoring advertising has cited such an issue. In a Feb. 3 letter posted on the FDA website this week, the Office of Prescription Drug Promotion wrote that Edenbridge Pharmaceuticals displayed a panel about its Hemady treatment for multiple myeloma in a conference e
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
MARCH 4, 2025
Denosumab-Bmwo is approved for all indications of the respective reference products, including osteoporosis and high-risk of fracture due to chemotherapy.
STAT
MARCH 4, 2025
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. Today, we talk about the likely confirmation of FDA nominee Marty Makary, go in-depth on NIH nominee Jay Bhattacharya, and see how much 23andMe CEO Anne Wojcicki is willing to pay for her own company.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
MARCH 4, 2025
Researchers determined the prevalence of weight management interventions among patients who were obese and received an obstructive sleep apnea diagnosis.
STAT
MARCH 4, 2025
After three years at the helm of controversial virtual mental health company Cerebral , David Mou has moved on and is ready to try again. He’s teamed up with Thomas Insel to form a new venture that hopes to address what the founders see as skewed incentives that sent many mental health companies down the wrong path. Mou and Insel are both psychiatrists and Insel, who led the National Institute of Mental Health for over a decade before a stint at Verily, has been a mentor to Mou through a
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
PharmaVoice
MARCH 4, 2025
Voyager Therapeutics’ progress with drug candidates targeting tau marks a step in how the industry is walking multiple paths toward new therapeutic options.
The Checkup by Singlecare
MARCH 4, 2025
Lamotrigine (brand name Lamictal) is a prescription anticonvulsant that’s FDA approved to treat epilepsy and maintenance treatment of bipolar I disorder. It may also be prescribed off-label to treat schizophrenia , trigeminal neuralgia , and fibromyalgia. Lamotrigine works by stabilizing mood and preventing seizures, making it a vital part of treatment plans for individuals facing these conditions.
PharmaVoice
MARCH 4, 2025
A recent study revealed the key barriers to enrollment and how pharma can help turn the tide.
Hospital Pharmacy Europe
MARCH 4, 2025
Medication errors frequently occur in emergency departments (EDs), placing a burden on both patients and healthcare systems. Enhanced integration of pharmacists to multidisciplinary ED teams could alleviate physician workload and improve patient care and safety, a recent study has found. This qualitative study explored physicians experiences of collaborating with pharmacists who joined emergency ED teams in two Norwegian hospitals, while also gauging their views on making such collaboration perm
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
PhRMA
MARCH 4, 2025
A tranche of recent reports reveal that the 340B hospital markup program is costing states and the federal government hundreds of millions of dollars in lost tax revenue.
Hospital Pharmacy Europe
MARCH 4, 2025
Some hormonal contraceptives are associated with a small but significant increased risk of stroke and myocardial infarction, according to a large and detailed study from Denmark. The analysis was based on national prescription records for more than two million Danish women between 1996 and 2021. It showed that contemporary oestrogen-progestin and progestin-only contraceptives were associated with an increased risk of arterial thrombotic events.
The Checkup by Singlecare
MARCH 4, 2025
Qsymia and phentermine are medications commonly prescribed for weight loss. Qsymia is a brand-name drug that contains two active ingredients, phentermine and extended-release topiramate. Phentermine is a generic drug, commonly known by brand names Adipex-P and Lomaira. While both drugs are commonly used for weight management, they are not exactly the same.
Pharmacy Times
MARCH 4, 2025
Additional risk factors included older age and advanced chronic kidney disease (CKD) stage.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
MARCH 4, 2025
The VA said its cuts are the first step in its audit of the roughly 90,000 contracts it currently has in placea process its announcement stressed is being conducted with in-house expertise and feedback. Specific plans for the savings will be shared "in the coming weeks and months," the department said.
Pharmaceutical Technology
MARCH 4, 2025
Large-scale integration of AI into pharma supply chains is on the way as companies seek optimised ordering.
Fierce Healthcare
MARCH 4, 2025
The Department of Government Efficiency has cancelled leases of federal buildings at the FDA and other agencies, as the feds look for alternative ways to divest office buildings.
Pharmacy Times
MARCH 4, 2025
Notable advancements include machine learning and predictive analytics, among others.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
MARCH 4, 2025
CVS is cutting loose from the ACO REACH value-based care program and is selling its Medicare Shared Savings Program business to Wellvana as the company looks to cut costs where possible.
Pharmaceutical Technology
MARCH 4, 2025
AstraZeneca's Imfinzi (durvalumab) plus chemotherapy, has gained CHMP recommendation for approval in the EU to treat NSCLC.
Fierce Healthcare
MARCH 4, 2025
Enhanced premium subsidies for Affordable Care Act plans are set to expire at the end of this year, and, if they do, the financial impacts would be felt in all 50 states, according to a new report.
STAT
MARCH 4, 2025
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. I’m Liz Cooney, sitting in on Morning Rounds for Theresa today.
Fierce Healthcare
MARCH 4, 2025
AvaSure, a virtual nursing technology and services company, unveiled a new AI-powered virtual care assistant for hospitals, dubbed "Vicky," that can interact directly with patients and triage their requests.
Pharmaceutical Technology
MARCH 4, 2025
ADCs are currently at the forefront of cancer treatment, but persistent drug development challenges call for a new approach.
Fierce Healthcare
MARCH 4, 2025
UnitedHealth Group notched a major court win in a legal challenge over its Medicare Advantage billing practices that is stretching into its second decade.
Pharmacy Times
MARCH 4, 2025
The FDA is issuing new changes to labels on testosterone products, clarifying that there are no increases in major cardiac events among men with hypogonadism but noting an increase in blood pressure with the use of such products.
pharmaphorum
MARCH 4, 2025
Eli Lilly has used an Oscars ad to urge people not to use unapproved and untested weight-loss medicines in a swipe at the compounding sector
Fierce Healthcare
MARCH 4, 2025
This story will be updated. | The Healthcare Information and Management Systems Society's Global Health Conference and Exhibition is taking place March 3-6 in Las Vegas.
pharmaphorum
MARCH 4, 2025
The ABPI has warned that declining access to new medicines in England will undermine the government's efforts to rebuild the NHS
Pharmacy Times
MARCH 4, 2025
RSV vaccine acceptance among older adults is significantly influenced by perceived benefits.
Pharmaceutical Technology
MARCH 4, 2025
Callio Therapeutics has raised $187m in Series A financing round for achieving clinical proof-of-concept for HER2-targeted dual-payload ADC.
Pharmacy Times
MARCH 4, 2025
Given the increasing age of patients with generalized myasthenia gravis, knowing which therapies are most effective for different subgroups is essential.
Fierce Healthcare
MARCH 4, 2025
Bluebird launched in 2024 to address pediatric care deserts, particularly acute for children enrolled in Medicaid. The practice aims to address the physical, mental and social needs of children.
Expert insights. Personalized for you.
666 
Let's personalize your content